Checkpoint Capital L.P. Quant / Systematic

CIK: 0001977548 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $149,629 (100.0% shares, 0.0% debt)

Holdings (17)

RYTM RHYTHM PHARMACEUTICALS INC 23.9%

Value ($000) $35,769 Shares 825,500 Est. Cost $32.96 Unrealized +32.8%

ARGX ARGENX SE 21.6%

Value ($000) $32,285 Shares 82,000 Est. Cost $382.37 Unrealized —

CYTK CYTOKINETICS INC 8.9%

Value ($000) $13,321 Shares 190,000 Est. Cost $36.21 Unrealized +113.6%

— AVADEL PHARMACEUTICALS PLC 7.9%

Value ($000) $11,846 Shares 701,387 Est. Cost $15.61 Unrealized —

AXSM AXSOME THERAPEUTICS INC 7.1%

Value ($000) $10,568 Shares 132,437 Est. Cost $66.86 Unrealized +25.5%

MIRM MIRUM PHARMACEUTICALS INC 6.1%

Value ($000) $9,098 Shares 362,193 Est. Cost $29.28 Unrealized -6.1%

PTGX PROTAGONIST THERAPEUTICS INC 5.4%

Value ($000) $8,109 Shares 280,301 Est. Cost $17.96 Unrealized +51.5%

CORT CORCEPT THERAPEUTICS INC 4.6%

Value ($000) $6,896 Shares 273,776 Est. Cost $23.63 Unrealized 0.0%

IRWD IRONWOOD PHARMACEUTICALS INC 3.6%

Value ($000) $5,387 Shares 618,528 Est. Cost $9.89 Unrealized +22.7%

PHAT PHATHOM PHARMACEUTICALS INC 3.2%

Value ($000) $4,728 Shares 445,161 Est. Cost $8.59 Unrealized -1.2%

ATYR ATYR PHARMA INC 1.9%

Value ($000) $2,821 Shares 1,446,477 Est. Cost $1.28 Unrealized +36.0%

VSTM VERASTEM INC 1.3%

Value ($000) $1,991 Shares 168,739 Est. Cost $11.55 Unrealized 0.0%

GHRS GH RESEARCH PLC 1.3%

Value ($000) $1,979 Shares 185,653 Est. Cost $7.06 Unrealized +12.5%

TRVI TREVI THERAPEUTICS INC 1.2%

Value ($000) $1,746 Shares 506,082 Est. Cost $1.51 Unrealized +47.4%

— APPLIED THERAPEUTICS INC 1.0%

Value ($000) $1,496 Shares 220,000 Est. Cost $6.80 Unrealized —

— ALLAKOS INC 0.6%

Value ($000) $968 Shares 767,964 Est. Cost $2.11 Unrealized —

— ATARA BIOTHERAPEUTICS INC 0.4%

Value ($000) $620 Shares 892,853 Est. Cost $0.69 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RYTM	RHYTHM PHARMACEUTICALS INC	825,500	$35,769	23.9%	$32.96	+32.8%	COM	76243J105
ARGX	ARGENX SE	82,000	$32,285	21.6%	$382.37	—	SPONSORED ADR	04016X101
CYTK	CYTOKINETICS INC	190,000	$13,321	8.9%	$36.21	+113.6%	COM NEW	23282W605
—	AVADEL PHARMACEUTICALS PLC	701,387	$11,846	7.9%	$15.61	—	SPONSORED ADR	05337M104
AXSM	AXSOME THERAPEUTICS INC	132,437	$10,568	7.1%	$66.86	+25.5%	COM	05464T104
MIRM	MIRUM PHARMACEUTICALS INC	362,193	$9,098	6.1%	$29.28	-6.1%	COM	604749101
PTGX	PROTAGONIST THERAPEUTICS INC	280,301	$8,109	5.4%	$17.96	+51.5%	COM	74366E102
CORT	CORCEPT THERAPEUTICS INC	273,776	$6,896	4.6%	$23.63	0.0%	COM	218352102
IRWD	IRONWOOD PHARMACEUTICALS INC	618,528	$5,387	3.6%	$9.89	+22.7%	COM CL A	46333X108
PHAT	PHATHOM PHARMACEUTICALS INC	445,161	$4,728	3.2%	$8.59	-1.2%	COM	71722W107
ATYR	ATYR PHARMA INC	1,446,477	$2,821	1.9%	$1.28	+36.0%	COM NEW	002120202
VSTM	VERASTEM INC	168,739	$1,991	1.3%	$11.55	0.0%	COM NEW	92337C203
GHRS	GH RESEARCH PLC	185,653	$1,979	1.3%	$7.06	+12.5%	ORDINARY SHARES	G3855L106
TRVI	TREVI THERAPEUTICS INC	506,082	$1,746	1.2%	$1.51	+47.4%	COM	89532M101
—	APPLIED THERAPEUTICS INC	220,000	$1,496	1.0%	$6.80	—	COM	03828A101
—	ALLAKOS INC	767,964	$968	0.6%	$2.11	—	COM	01671P100
—	ATARA BIOTHERAPEUTICS INC	892,853	$620	0.4%	$0.69	—	COM	046513107